2027 National Institute Of Neurological Disorders and Stroke (NINDS) Chronic Traumatic Encephalopathy (CTE) Summit

2027 National Institute Of Neurological Disorders and Stroke (NINDS) Chronic Traumatic Encephalopathy (CTE) Summit is organized by National Institute Of Neurological Disorders and Stroke (NINDS) and will be held from Jan 28 - 29, 2027 at Natcher Conference Center, Bethesda, Maryland, United States of America.

Description:
The meeting will bring together investigators, clinicians, neuropathologists, epidemiologists, imaging and biomarker experts, early-stage investigators, and stakeholders from across the CTE research community. Sessions will highlight:

• Evidence on the validity, reliability, and feasibility of the TES criteria in different settings and populations
• Progress in in vivo diagnostic tools, including neuroimaging, fluid biomarkers, and digital/functional measures
• Integration of clinical, biomarker, and neuropathological data to refine disease staging and prognosis
• Implications of current evidence for clinical trials, including patient selection, outcome measures, and ethical considerations
• Opportunities to inform NINDS and broader NIH efforts by addressing emerging CTE-related research and clinical needs.

Summit Goals:

1. Review the current state of CTE research, including but not limited to NINDS-funded studies, across clinical, neuropathological, imaging, biomarker, and epidemiological domains.
2. Evaluate the readiness of the TES diagnostic criteria for use in settings beyond observational research, including clinical trials and, where appropriate, clinical care.